Massmutual Trust »

Entrada Therapeutics shares owned by Massmutual Trust

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Massmutual Trust from 13F filings

Historical chart of Massmutual Trust investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Massmutual Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Massmutual Trust

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.3k 186 12.62
2025-12-31 $1.9k 186 10.28

More positions owned by Massmutual Trust

NVIDIA Corp Common / Ordinary Stock (NVDA)
Apple Common / Ordinary Stock (AAPL)
Vanguard Mid-Cap ETF Exchange Traded Fund (VO)
Microsoft Corp Common / Ordinary Stock (MSFT)
Vanguard FTSE Developed Markets ETF Exchange Traded Fund (VEA)
Amazon.com Common / Ordinary Stock (AMZN)
Alphabet Common / Ordinary Stock (GOOGL)
JPMorgan Chase & Co Common / Ordinary Stock (JPM)
Broadcom Common / Ordinary Stock (AVGO)
Alphabet Common / Ordinary Stock (GOOG)
Chevron Corp Common / Ordinary Stock (CVX)
iShares MSCI EAFE ETF Exchange Traded Fund (EFA)
Meta Platforms Common / Ordinary Stock (META)
Dimensional US Small Cap ETF Exchange Traded Fund (DFAS)
iShares Core S&P Mid-Cap ETF Exchange Traded Fund (IJH)

View all positions for Massmutual Trust

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
TCG Crossover Management
Vanguard Group
Wellington Management Company
StepStone
Geode Capital Management
State Street Corporation
Millennium Management
Jacobs Levy Equity Management
Acadian Asset Management
Citadel Advisors
Dimensional Fund Advisors
Renaissance Technologies

View all funds holding Entrada Therapeutics